Identification of novel immuno-oncology compounds as VISTA-inhibitors for cancer therapy: A computational approach integrating virtual screening and molecular dynamics simulation

Identification of novel immuno-oncology compounds as VISTA-inhibitors for cancer therapy: A computational approach integrating virtual screening and molecular dynamics simulation

The landscape of cancer treatment has witnessed a paradigm shift with the emergence of immunotherapy, particularly the inhibition of immune checkpoints like programmed cell death protein 1 (PD-1) and its ligand PD-L1. While these therapies have revolutionized cancer treatment, a substantial proporti...

Descrición completa

Detalles Bibliográficos
Main Authors: Winner Amaka Egejuru, Olajide Enoch Aderemi, Abel Ujaigbe Egbemhenghe, Muhammad Qasim Ali, Dolapo Emmanuel Opasina, Cyril Obaro Agadagba, Emmanuel Parkay Oladokun, Ibrahim Tope Abdulrazaq, Maryam Folake Ayinla, Abiodun Bamidele, Olamide Oluwagbeminiyi Alayemi, Latifat Akorede Adebowale, Folakemi Monsurat Adebayo, Bamidele Samson Omotara
Formato: Artigo
Idioma:English
Publicado: Elsevier 2024-01-01
Series:Informatics in Medicine Unlocked
Subjects:
Virtual screening
Molecular docking
Molecular dynamics simulation
VISTA
Immune-oncology and cancer therapy
Acceso en liña:http://www.sciencedirect.com/science/article/pii/S2352914824000170

Internet

http://www.sciencedirect.com/science/article/pii/S2352914824000170

Títulos similares